Biotechnology company, Altimmune, Inc. (ALT) continues to gain on Wednesday, despite no corporate-specific news to influence the stock movement.
Currently, Altimmune's stock is climbing 3.28%, to $11.33 from the previous close of $10.97 on a volume of 5,068,608.
In the past 52 week period, the stock has traded between $2.09 and $17.17.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.